Skip to main content

Table 3 Lipid and hormone plasma levels in MI-resistant patients at baseline and after MI plus α-LA treatment

From: Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women

Plasma levels of: Baseline End of treatment p
Total cholesterol (mg/dl) 211 ± 22 190 ± 26 ≤ 0.05
HDL (mg/dl) 35 ± 8 37 ± 6 n.s.
LDL (mg/dl) 128 ± 21 127 ± 20 n.s.
Triglycerides (mg/dl) 186 ± 51 119 ± 38 ≤ 0.05
Progesterone (ng/ml) 0.7 ± 0.3 0.6 ± 0.1 n.s.
Testosterone (ng/dl) 88 ± 38 57 ± 31 ≤ 0.05
Free testosterone (ng/dl) 1.3 ± 0.5 0.6 ± 0.3 <  0.001
Androstenedione (ng/dl) 198 ± 59 165 ± 47 n.s.
17β-estradiol (ng/dl) 9.1 ± 3.7 9.2 ± 3.9 n.s.
Dehydroepiandrosterone sulfate (μg/dl) 530 ± 231 279 ± 87 <  0.01
SHBG (μg/dl) 2.6 ± 0.9 5.0 ± 2.1 <  0.001
  1. Values are expressed as mean ± SD. p: value at end of treatment vs baseline
  2. Instead, no significant changes were detected in the two MI-resistant women (data not shown)